New Technology is Revolutionizing Clinical Trial Data Management — Here’s How Research Hospitals Can Seize the Moment Read More June 3, 2026
FDA Concerns About Cancer Risk Sink Fulcrum Therapeutics’ Sickle Cell Disease Drug Read More June 2, 2026
Servier Moves Into Muscular Dystrophy, Paying $1.5B for Assets From Edgewise Therapeutics Read More June 1, 2026